Previous 10 | Next 10 |
2023-03-09 23:03:35 ET Summary Carl Icahn’s 13F portfolio value increased from $21.23B to $21.75B this quarter. They decreased Cheniere Energy substantially this quarter. Icahn Enterprises, CVR Energy, and FirstEnergy are the three largest positions. This arti...
Summary Carl Icahn’s 13F portfolio value decreased from $21.87B to $20.86B this quarter. They reduced Cheniere Energy while increasing Southwest Gas Holdings. Icahn Enterprises, CVR Energy, and Cheniere Energy are the three largest positions. This article is p...
Carl Icahn’s 13F portfolio value decreased from $22.29B to $21.87B this quarter. They reduced Cheniere Energy and Newell Brands during the quarter. They also dropped Occidental Petroleum. Icahn Enterprises, CVR Energy, and Cheniere Energy are the three largest positions. ...
Carl Icahn’s 13F portfolio value decreased from $22.52B to $22.29B this quarter. They increased Southwest Gas Holdings during the quarter. Icahn Enterprises, Cheniere Energy, and Occidental Petroleum are the three largest positions. For further details see: Tracki...
Carl Icahn’s 13F portfolio value increased from $23.85B to $24.29B this quarter. They decreased Occidental Petroleum and dropped Herbalife during the quarter. Icahn Enterprises, Occidental Petroleum, and Cheniere Energy are the three largest positions. For further det...
Carl Icahn’s 13F portfolio value increased from $20.06B to $23.85B this quarter. They added FirstEnergy and increased Bausch Health & Dana Inc. while reducing Herbalife. Icahn Enterprises, Occidental Petroleum, and CVR Energy are the three largest positions. For f...
Carl Icahn’s 13F portfolio value increased from $17.37B to $20.06B this quarter. They added Bausch Health and Dana Corp. while reducing Cheniere Energy. Icahn Enterprises, Occidental Petroleum, and CVR Energy are the three largest positions. For further details see: ...
Enzon Pharmaceuticals ([[ENZN]] +1.6%) announces today that Andrew Rackear will retire from his role as CEO effective February 26, 2021.Richard L. Feinstein, CFO, will also assume the role of CEO and Secretary, as well as remain the CFO.Mr. Rackear will be available as a c...
CRANFORD, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTC:ENZN) announced today that Andrew Rackear has communicated to the Board his intent to retire from his role as the Company’s Chief Executive Officer effective February 26, 2021. Andy joined Enzon in 201...
Carl Icahn’s 13F portfolio value decreased from $19.72B to $17.37B this quarter. Xerox was increased while decreasing Herbalife and dropping Caesars Entertainment. Also, some Occidental Petroleum warrants (22 strike, 8/3/2027 expiry) were acquired during the quarter. Icahn ...
News, Short Squeeze, Breakout and More Instantly...
Enzon Pharmaceuticals Inc Company Name:
ENZN Stock Symbol:
OTCMKTS Market:
Enzon Pharmaceuticals Inc Website:
Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...
Commercial National Financial Corp. (CNAF) is expected to report for Q1 2024 First National Bank Alaska (FBAK) is expected to report for Q1 2024 Cyxtera Technologies Inc. (CYXTQ) is expected to report for quarter end 2024-03-31 Brookfield Renewable Corporation Class A Subordinate (BEP...
AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...